Hiddo Lambers Heerspink

Zoekresultaten

• 2022

  Erratum to: Precision medicine approaches for diabetic kidney disease: opportunities and challenges

  Tye, S. C., Denig, P. & Heerspink, H. J. L., jun.-2022, In: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 37, 6, 1 blz., gfab296.

  Onderzoeksoutput

  Open Access

  Bestand
  1 Citaat (Scopus)

  46 Downloads (Pure)
• 2018

  Erratum: Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease

  Dekkers, C. C. J., Wheeler, D. C., Sjöström, C. D., Stefansson, B. V., Cain, V. & Heerspink, H. J. L., 1-jul.-2018, In: Nephrology, Dialysis, Transplantation. 33, 7, blz. 1280 1 blz.

  Onderzoeksoutput

  Open Access

  Bestand
  6 Citaten (Scopus)

  161 Downloads (Pure)
• 2015

  Erratum to: Abstracts of the 51st Annual Meeting of the EASD, Stockholm 2015. 'Dapagliflozin reduces albuminuria on top of renin-angiotensin system blockade in hypertensive patients with diabetes' (vol 58, pg 1, 2015)

  Heerspink, H. J. L., Johnsson, E., Gause-Nilsson, I. & Sjostrom, C., dec.-2015, In: Diabetologia. 58, 12, blz. 2901 1 blz.

  Onderzoeksoutput
  1 Citaat (Scopus)
• 2014

  CORRECTION: The effect of RAAS blockade on the progression of diabetic nephropathy

  Roscioni, S. S., Lambers Heerspink, H. & de Zeeuw, D., mei-2014, In: Nature Reviews Nephrology. 10, 5, blz. 243-243 1 blz.

  Onderzoeksoutput